touchONCOLOGY are joined by the EAU Section of Oncological Urology (ESOU) Chairman Professor Morgan Rouprêt to discuss the impact of immune checkpoint inhibitors on the treatment of bladder cancer, and other exciting therapeutic advances.
Questions
- How have immune checkpoint inhibitors changed the treatment landscape for bladder cancer? (00:35-03:35)
- What are the most exciting recent and emerging therapeutic advances in bladder cancer? (03:35-05:05)
Speaker Disclosure: Morgan Rouprêt has no conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the EAU Section of Oncological Urology (ESOU) 2022 conference.
